Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Selective decrease in hepatitis C virus-specific immunity among African Americans and outcome of antiviral therapy.

Hepatology (Baltimore, Md.) - 1 Aug 2007

Rosen Hugo R, Weston Scott J, Im KyungAh, Yang Huiying, Burton James R, Erlich Henry, Klarquist Jared, Belle Steven H

Abstract excerpt

UNLABELLED: Hepatitis C virus (HCV) infection is a leading cause of chronic hepatitis, end-stage liver disease, and hepatocellular carcinoma throughout the world. Considerable evidence indicates that the risk of viral persistence, natural history, and response to antiviral therapy varies among racial groups, but limited data exist on potential mechanisms to account for these differences. Type 1 helper (Th1)...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cytomegalovirus
Share to Genes, MHC Class II

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Interferon-alpha

Share to Interferon alpha-2

Share to Interferon-gamma

Share to Polyethylene Glycols

Share to Ribavirin

Share to Th1 Cells

Source

Identifiers

PMID: 17659573
DOI: 10.1002/hep.21714

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Selective decrease in hepatitis C virus-specific immunity among African Americans and outcome of antiviral therapy.PMID 17659573Read ↗

Influence of ethnicity in the outcome of hepatitis C virus infection and cellular immune response.Semantic proximity Read ↗

Human leukocyte antigen class II associations with hepatitis C virus clearance and virus-specific CD4 T cell response among Caucasians and African Americans.Semantic proximity Read ↗

Peginterferon and ribavirin treatment in African American and Caucasian American patients with hepatitis C genotype 1.Semantic proximity Read ↗

Sustained virological response rate to pegylated interferon plus ribavirin for chronic hepatitis C in African Americans: results in treatment-naïve patients in a university liver clinic.Semantic proximity Read ↗

Contribution of genome-wide HCV genetic differences to outcome of interferon-based therapy in Caucasian American and African American patients.Semantic proximity Read ↗

T-cell response relative to genotype and ethnicity during antiviral therapy for chronic hepatitis C.Semantic proximity Read ↗

Cutting edge: programmed death-1 expression is increased on immunocytes in chronic hepatitis C virus and predicts failure of response to antiviral therapy: race-dependent differences.Semantic proximity Read ↗

Immune responses to hepatitis C and non-hepatitis C antigens in hepatitis C virus infected and HIV-1 coinfected patients.Semantic proximity Read ↗

Associations between the human MHC and sustained virologic response in the treatment of chronic hepatitis C virus infection.Semantic proximity Read ↗

Strain-specific T-cell suppression and protective immunity in patients with chronic hepatitis C virus infection.Semantic proximity Read ↗

Treatment of chronic hepatitis C virus in African Americans with genotypes 2 and 3.Semantic proximity Read ↗

Outcome of acute hepatitis C is related to virus-specific CD4 function and maturation of antiviral memory CD8 responsesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.